Abdorreza Naser Moghadasi. (2021). Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients. Tehran University of Medical Sciences.
Chicago Style (17th ed.) CitationAbdorreza Naser Moghadasi. Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients. Tehran University of Medical Sciences, 2021.
MLA (9th ed.) CitationAbdorreza Naser Moghadasi. Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients. Tehran University of Medical Sciences, 2021.
Warning: These citations may not always be 100% accurate.